Kakuda, Thomas N.
Janssen Research & Development,
Belgium
2025 Rank: 141582
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Virology
Rank in SubField 1: 1319 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 141582 | 146398 |
| Total Cites | 3157 | 3553 |
| H-index | 28 | 32 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 546 | 548 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 1335 | 1446 |
| Number of Single+First+Last Authored Papers | 47 | 47 |
| Total Cites to Single+First+Last Authored Papers | 1554 | 1682 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2382 | 2554 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.39 |
| Self-Citation Percentage |
11.15%
|
|
Kakuda, Thomas N.
Janssen Research & Development,
United States
2024 Rank: 134253
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Virology
Rank in SubField 1: 1274 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 134253 | 139099 |
| Total Cites | 3041 | 3428 |
| H-index | 28 | 32 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 535 | 537 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 1309 | 1420 |
| Number of Single+First+Last Authored Papers | 47 | 47 |
| Total Cites to Single+First+Last Authored Papers | 1520 | 1648 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2289 | 2453 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.40 |
| Self-Citation Percentage |
11.29%
|
|
Kakuda, Thomas N.
Janssen Research & Development,
United States
2023 Rank: 129407
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Virology
Rank in SubField 1: 1247 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 129407 | 133869 |
| Total Cites | 2925 | 3301 |
| H-index | 27 | 31 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 527 | 529 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 1269 | 1381 |
| Number of Single+First+Last Authored Papers | 46 | 46 |
| Total Cites to Single+First+Last Authored Papers | 1475 | 1604 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2201 | 2357 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.40 |
| Self-Citation Percentage |
11.39%
|
|
Kakuda, Thomas N.
Janssen Biopharma,
United States
2022 Rank: 119866
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Virology
Rank in SubField 1: 1154 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 119866 | 126743 |
| Total Cites | 2794 | 3159 |
| H-index | 27 | 30 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 509 | 511 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 1222 | 1333 |
| Number of Single+First+Last Authored Papers | 46 | 46 |
| Total Cites to Single+First+Last Authored Papers | 1422 | 1550 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2092 | 2239 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.41 |
| Self-Citation Percentage |
11.55%
|
|
Kakuda, Thomas N.
Clinical Pharmacology,
United States
2021 Rank: 115597
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Virology
Rank in SubField 1: 1128 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 115597 | 123985 |
| Total Cites | 2699 | 3057 |
| H-index | 27 | 30 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 490 | 492 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 1188 | 1297 |
| Number of Single+First+Last Authored Papers | 45 | 45 |
| Total Cites to Single+First+Last Authored Papers | 1377 | 1502 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2020 | 2166 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.41 |
| Self-Citation Percentage |
11.71%
|
|
Kakuda, Thomas N.
Clinical Pharmacology,
United States
2020 Rank: 109433
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Virology
Rank in SubField 1: 1017 out of 94611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 109433 | 116272 |
| Total Cites | 2540 | 2885 |
| H-index | 26 | 29 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 477 | 479 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 1129 | 1238 |
| Number of Single+First+Last Authored Papers | 45 | 45 |
| Total Cites to Single+First+Last Authored Papers | 1309 | 1434 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1898 | 2037 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.42 |
| Self-Citation Percentage |
11.96%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.